Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$30.70
-0.56-1.79%
Pre-Market: 6:39 AM EDT
Comments
Loading...
Supernus Pharmaceuticals Stock Price, Quotes and Forecasts
SUPNNASDAQ
Supernus Pharmaceuticals (SUPN) Forecast
NewsEarningsSupernus Pharmaceuticals (SUPN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Supernus Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:SUPN | Benzinga
Explore Supernus Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SUPN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Supernus Pharmaceuticals (SUPN) stock?
You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.
Who are Supernus Pharmaceuticals (SUPN) competitors?
Other companies in Supernus Pharmaceuticals’s space includes: WAVE Life Sciences (NASDAQ:WVE), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and ANI Pharmaceuticals (NASDAQ:ANIP).
What is the forecast, or price target, for Supernus Pharmaceuticals (SUPN) stock?
Supernus Pharmaceuticals has a consensus price target of $36.00.
What is the current price for Supernus Pharmaceuticals (SUPN)?
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $30.7 last updated March 17, 2025 at 6:39 AM EDT.
Does Supernus Pharmaceuticals (SUPN) pay a dividend?
There are no upcoming dividends for Supernus Pharmaceuticals.
When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?
Supernus Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Supernus Pharmaceuticals (SUPN) going to split?
There is no upcoming split for Supernus Pharmaceuticals.
What sector and industry does Supernus Pharmaceuticals (SUPN) operate in?
Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.